SEOUL– Hanmi Pharm Co. on Tuesday reported its third-quarter net profit of 31.3 billion won (US$22.1 million), up 11.5 percent from a year earlier.
The company said in a regulatory filing that it posted 46.8 billion won in operating profit for the quarter, compared with 36.9 billion won a year ago. Sales rose 12.9 percent to 342.1 billion won.
The earnings beat market expectations. The average estimate of net profit by analysts stood at 23.2 billion won, according to a survey by Yonhap Infomax, the financial data firm of Yonhap News Agency.
Source: Yonhap News Agency